Unveiling the Multifaceted Problems Associated with Dysrhythmia.

Adrianna Witczyńska, Aidas Alaburda, Grzegorz Grześk, Jacek Nowaczyk, Alicja Nowaczyk
Author Information
  1. Adrianna Witczyńska: Department of Organic Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 87-100 Toruń, Poland.
  2. Aidas Alaburda: Department of Neurobiology and Biophysics, Institute of Bioscience, Vilnius University Saulėtekio Ave. 7, LT-10257 Vilnius, Lithuania. ORCID
  3. Grzegorz Grześk: Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 87-100 Toruń, Poland. ORCID
  4. Jacek Nowaczyk: Department of Physical Chemistry and Physicochemistry of Polymers, Faculty of Chemistry, Nicolaus Copernicus University, 7 Gagarina St., 87-100 Toruń, Poland. ORCID
  5. Alicja Nowaczyk: Department of Organic Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 87-100 Toruń, Poland. ORCID

Abstract

Dysrhythmia is a term referring to the occurrence of spontaneous and repetitive changes in potentials with parameters deviating from those considered normal. The term refers to heart anomalies but has a broader meaning. Dysrhythmias may concern the heart, neurological system, digestive system, and sensory organs. Ion currents conducted through ion channels are a universal phenomenon. The occurrence of channel abnormalities will therefore result in disorders with clinical manifestations depending on the affected tissue, but phenomena from other tissues and organs may also manifest themselves. A similar problem concerns the implementation of pharmacotherapy, the mechanism of which is related to the impact on various ion currents. Treatment in this case may cause unfavorable effects on other tissues and organs. Drugs acting through the modulation of ion currents are characterized by relatively low tissue specificity. To assess a therapy's efficacy and safety, the risk of occurrences in other tissues with similar mechanisms of action must be considered. In the present review, the focus is shifted prominently onto a comparison of abnormal electrical activity within different tissues and organs. This review includes an overview of the types of Dysrhythmias and the basic techniques of clinical examination of electrophysiological disorders. It also presents a concise overview of the available pharmacotherapy in particular diseases. In addition, the authors review the relevant ion channels and their research technique based on patch clumping.

Keywords

References

  1. Epilepsia. 2023 Sep;64(9):2361-2372 [PMID: 37329175]
  2. Mayo Clin Proc. 2001 Feb;76(2):226-34 [PMID: 11213315]
  3. Lancet Neurol. 2023 Jan;22(1):89-100 [PMID: 36155661]
  4. Bio Protoc. 2023 Mar 20;13(6):e4632 [PMID: 36968440]
  5. Clin Ophthalmol. 2007 Sep;1(3):233-46 [PMID: 19668477]
  6. Methods Cell Biol. 1994;40:135-51 [PMID: 8201974]
  7. Eur Heart J Suppl. 2020 Dec 22;22(Suppl O):O1-O13 [PMID: 33380940]
  8. Front Pharmacol. 2020 May 12;11:616 [PMID: 32477118]
  9. Neurogastroenterol Motil. 2021 Mar;33(3):e14048 [PMID: 33274564]
  10. Int J Mol Sci. 2021 Aug 08;22(16): [PMID: 34445237]
  11. Cells. 2022 Jan 25;11(3): [PMID: 35159225]
  12. Front Endocrinol (Lausanne). 2019 Nov 22;10:794 [PMID: 31824418]
  13. Anesth Analg. 1990 Jan;70(1):125-6 [PMID: 2297096]
  14. Aliment Pharmacol Ther. 2011 Dec;34(11-12):1269-81 [PMID: 21999643]
  15. J Pharmacol Toxicol Methods. 2021 Jul-Aug;110:107072 [PMID: 33962018]
  16. CNS Drugs. 2021 Sep;35(9):935-963 [PMID: 34145528]
  17. N Engl J Med. 2018 Jan 18;378(3):270-280 [PMID: 29342392]
  18. Pharmacol Rev. 2015 Oct;67(4):821-70 [PMID: 26362469]
  19. Doc Ophthalmol. 2017 Feb;134(1):1-9 [PMID: 28110380]
  20. J Pharmacokinet Pharmacodyn. 2018 Jun;45(3):365-381 [PMID: 29736890]
  21. Int J Mol Med. 2022 Jul;50(1): [PMID: 35616162]
  22. Circ Res. 2006 Apr 28;98(8):1055-63 [PMID: 16556865]
  23. Am J Physiol. 1989 Jan;256(1 Pt 2):H21-31 [PMID: 2912184]
  24. Int J Mol Sci. 2020 Dec 30;22(1): [PMID: 33396592]
  25. Pharmacol Res. 2020 Apr;154:104166 [PMID: 30731197]
  26. J Pharmacol Toxicol Methods. 2016 Sep-Oct;81:251-62 [PMID: 27060526]
  27. Circulation. 2018 Dec 4;138(23):e740-e749 [PMID: 30571262]
  28. Adv Protein Chem Struct Biol. 2016;104:157-231 [PMID: 27038375]
  29. Prog Retin Eye Res. 2023 Jul;95:101136 [PMID: 36400670]
  30. BMJ. 2021 Mar 29;372:n71 [PMID: 33782057]
  31. Ann Transl Med. 2021 Aug;9(15):1276 [PMID: 34532413]
  32. Prog Retin Eye Res. 2019 Sep;72:100760 [PMID: 31078724]
  33. Circulation. 1998 Jun 23;97(24):2420-5 [PMID: 9641694]
  34. Pharmacotherapy. 2021 Feb;41(2):198-204 [PMID: 33465818]
  35. Molecules. 2021 Jun 09;26(12): [PMID: 34207748]
  36. Indian J Ophthalmol. 2021 Jan;69(1):27-35 [PMID: 33323567]
  37. Front Cardiovasc Med. 2021 Feb 22;8:625449 [PMID: 33693037]
  38. Adv Exp Med Biol. 2017;981:23-39 [PMID: 29594856]
  39. Front Pharmacol. 2023 Jan 09;13:1043714 [PMID: 36699057]
  40. Circ Arrhythm Electrophysiol. 2023 Jul;16(7):399-410 [PMID: 37334695]
  41. Cortex. 2023 May;162:1-11 [PMID: 36948090]
  42. Front Cardiovasc Med. 2023 Jun 20;10:1171647 [PMID: 37408656]
  43. Cureus. 2021 Jan 18;13(1):e12759 [PMID: 33614352]
  44. Prog Retin Eye Res. 2007 Jul;26(4):359-78 [PMID: 17446115]
  45. Clin Neurophysiol. 2009 Oct;120(10):1806-11 [PMID: 19748828]
  46. Doc Ophthalmol. 2022 Jun;144(3):165-177 [PMID: 35511377]
  47. Springerplus. 2014 Oct 15;3:603 [PMID: 25392776]
  48. Int J Environ Res Public Health. 2019 May 05;16(9): [PMID: 31060319]
  49. ESC Heart Fail. 2021 Oct;8(5):3663-3689 [PMID: 34374223]
  50. J Neuroophthalmol. 2018 Jun;38(2):167-171 [PMID: 29300238]
  51. J Med Life. 2020 Jan-Mar;13(1):3-7 [PMID: 32341693]
  52. Eye (Lond). 2021 Sep;35(9):2406-2418 [PMID: 34234290]
  53. Pharmaceuticals (Basel). 2023 Jun 06;16(6): [PMID: 37375791]
  54. Epilepsy Behav. 2023 Apr;141:109141 [PMID: 36871317]
  55. Am J Physiol Cell Physiol. 2018 Aug 1;315(2):C236-C246 [PMID: 29669221]
  56. Molecules. 2023 Dec 11;28(24): [PMID: 38138529]
  57. Front Neurosci. 2023 Mar 01;17:1055445 [PMID: 36937689]
  58. Am J Ophthalmol. 1990 Dec 15;110(6):665-9 [PMID: 2248332]
  59. Br Heart J. 1967 Nov;29(6):926-36 [PMID: 4228665]
  60. Ann Neurosci. 2023 Jan;30(1):26-32 [PMID: 37313334]
  61. Heart. 2022 Mar;108(5):332-338 [PMID: 34039680]
  62. Lancet Neurol. 2022 Dec;21(12):1120-1134 [PMID: 36179757]
  63. J Interv Card Electrophysiol. 2019 Mar;54(2):189-196 [PMID: 30353374]
  64. Curr Opin Ophthalmol. 2018 May;29(3):234-238 [PMID: 29538182]
  65. Gastroenterology. 2022 Apr;162(4):1334-1342 [PMID: 35183361]
  66. Rev Cardiovasc Med. 2022 Jan 20;23(1):38 [PMID: 35092230]
  67. Invest Ophthalmol Vis Sci. 1995 May;36(6):1084-7 [PMID: 7730017]
  68. Int J Mol Sci. 2016 Aug 01;17(8): [PMID: 27490534]
  69. Eur Heart J. 2021 Feb 1;42(5):373-498 [PMID: 32860505]
  70. Nutrients. 2020 Aug 31;12(9): [PMID: 32878163]
  71. Eur Heart J. 2020 Feb 1;41(5):655-720 [PMID: 31504425]
  72. Curr Opin Ophthalmol. 1998 Dec;9(6):33-9 [PMID: 10387334]
  73. Kardiol Pol. 2009 Nov;67(11):1268-73 [PMID: 20024856]
  74. Front Cell Neurosci. 2016 Mar 30;10:81 [PMID: 27064559]
  75. Circulation. 2018 Oct 23;138(17):1879-1896 [PMID: 30354657]
  76. J Mol Cell Cardiol. 1987 May;19(5):441-51 [PMID: 3625781]
  77. Int J Environ Res Public Health. 2022 Mar 06;19(5): [PMID: 35270784]
  78. Front Pharmacol. 2020 Apr 15;11:428 [PMID: 32351386]
  79. Neurogastroenterol Motil. 2003 Apr;15(2):89-102 [PMID: 12680908]
  80. IEEE Trans Biomed Eng. 2017 Jul;64(7):1592-1601 [PMID: 28113227]
  81. Heart Lung Circ. 2018 Apr;27(4):443-450 [PMID: 29233498]
  82. Health Informatics J. 2020 Mar;26(1):449-460 [PMID: 30859886]
  83. Therap Adv Gastroenterol. 2019 Apr 02;12:1756284819832237 [PMID: 30984290]
  84. Handb Clin Neurol. 2013;117:379-93 [PMID: 24095141]
  85. Front Physiol. 2021 Jan 08;11:583082 [PMID: 33488391]
  86. Europace. 2021 Apr 10;23(23 Suppl 2):ii14-ii22 [PMID: 33837753]
  87. Front Pharmacol. 2016 May 10;7:121 [PMID: 27242528]
  88. Stem Cells. 2005 Mar;23(3):371-82 [PMID: 15749932]
  89. Dig Dis. 1995 Sep-Oct;13(5):275-90 [PMID: 8542663]
  90. Medicina (Kaunas). 2019 Sep 13;55(9): [PMID: 31540311]
  91. Int J Mol Sci. 2020 May 25;21(10): [PMID: 32466222]
  92. Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3727-32 [PMID: 15452083]
  93. J Clin Med. 2021 Nov 19;10(22): [PMID: 34830678]
  94. J Neurol Sci. 2019 Nov 15;406:116428 [PMID: 31574325]
  95. Pract Neurol. 2020 May;20(3):189-198 [PMID: 31892545]
  96. Expert Opin Drug Saf. 2019 Nov;18(11):1043-1053 [PMID: 31498687]
  97. Int J Mol Sci. 2020 Oct 30;21(21): [PMID: 33143033]
  98. Front Physiol. 2020 Jul 23;11:779 [PMID: 32792970]
  99. J Clin Med. 2021 Apr 06;10(7): [PMID: 33917535]
  100. Compr Physiol. 2015 Apr;5(2):761-90 [PMID: 25880512]
  101. J Clin Med. 2020 Jun 18;9(6): [PMID: 32570709]
  102. Eye (Lond). 2004 Nov;18(11):1066-74 [PMID: 15534591]
  103. Aliment Pharmacol Ther. 2020 Sep;52(6):988-996 [PMID: 32767824]
  104. Neuroscience. 2020 Aug 1;440:337-359 [PMID: 32473276]
  105. Epilepsy Behav. 2002 Aug;3(4):395-401 [PMID: 12609340]
  106. Ann Clin Transl Neurol. 2021 Jul;8(7):1557-1568 [PMID: 34047488]
  107. Drug Discov Today. 2019 Jul;24(7):1389-1397 [PMID: 31129313]
  108. J Pharmacol Toxicol Methods. 2005 May-Jun;51(3):187-200 [PMID: 15862464]
  109. Epilepsia. 2017 Apr;58(4):531-542 [PMID: 28276064]
  110. J Am Coll Cardiol. 2008 May 6;51(18):1725-33 [PMID: 18452777]
  111. Drug Saf. 2008;31(2):127-41 [PMID: 18217789]
  112. Curr Opin Neurol. 2023 Apr 1;36(2):77-85 [PMID: 36762638]
  113. Epilepsia. 2023 Apr;64(4):866-874 [PMID: 36734057]
  114. J Clin Med. 2021 May 21;10(11): [PMID: 34064035]
  115. J Clin Med. 2022 Jul 11;11(14): [PMID: 35887772]
  116. Expert Opin Pharmacother. 2022 Dec;23(18):2023-2034 [PMID: 36154780]
  117. Prog Retin Eye Res. 2007 May;26(3):263-301 [PMID: 17258931]
  118. Trends Pharmacol Sci. 2021 Dec;42(12):1035-1050 [PMID: 34674886]
  119. Clin Neurophysiol. 2001 Jul;112(7):1186-95 [PMID: 11516730]
  120. Doc Ophthalmol. 2018 Feb;136(1):1-26 [PMID: 29397523]
  121. Cyborg Bionic Syst. 2023 May 31;4:0034 [PMID: 37266026]
  122. Europace. 2016 Oct;18(10):1455-1490 [PMID: 27402624]
  123. J Cardiovasc Electrophysiol. 2006 Jun;17(6):691-4 [PMID: 16836727]
  124. Esophagus. 2021 Jul;18(3):425-435 [PMID: 33594598]
  125. Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4182-7 [PMID: 9108126]
  126. Cells. 2019 Jul 02;8(7): [PMID: 31269763]

MeSH Term

Humans
Arrhythmias, Cardiac
Heart
Ion Transport
Research Design
Ion Channels

Chemicals

Ion Channels

Word Cloud

Created with Highcharts 10.0.0organsiontissuesmaycurrentspharmacotherapyreviewDysrhythmiatermoccurrenceconsideredheartsystemchannelsdisordersclinicaltissuealsosimilaroverviewtechniquespatchreferringspontaneousrepetitivechangespotentialsparametersdeviatingnormalrefersanomaliesbroadermeaningDysrhythmiasconcernneurologicaldigestivesensoryIonconducteduniversalphenomenonchannelabnormalitieswillthereforeresultmanifestationsdependingaffectedphenomenamanifestproblemconcernsimplementationmechanismrelatedimpactvariousTreatmentcasecauseunfavorableeffectsDrugsactingmodulationcharacterizedrelativelylowspecificityassesstherapy'sefficacysafetyriskoccurrencesmechanismsactionmustpresentfocusshiftedprominentlyontocomparisonabnormalelectricalactivitywithindifferentincludestypesdysrhythmiasbasicexaminationelectrophysiologicalpresentsconciseavailableparticulardiseasesadditionauthorsrelevantresearchtechniquebasedclumpingUnveilingMultifacetedProblemsAssociateddysrhythmiaelectrobiologicalclamp

Similar Articles

Cited By

No available data.